Next Article in Journal
N6-Methyladenosine Modification of CIRCKRT17 Initiated by METTL3 Promotes Osimertinib Resistance of Lung Adenocarcinoma by EIF4A3 to Enhance YAP1 Stability
Next Article in Special Issue
Gastric Cancer and the Immune System: The Key to Improving Outcomes?
Previous Article in Journal
Gallbladder Cancer: Current Multimodality Treatment Concepts and Future Directions
Previous Article in Special Issue
The Role of miR-155 in Antitumor Immunity
 
 
Article

Article Versions Notes

Cancers 2022, 14(22), 5576; https://doi.org/10.3390/cancers14225576
Action Date Notes Link
article xml file uploaded 14 November 2022 11:23 CET Original file -
article xml uploaded. 14 November 2022 11:23 CET Update -
article pdf uploaded. 14 November 2022 11:23 CET Version of Record https://www.mdpi.com/2072-6694/14/22/5576/pdf-vor
article html file updated 14 November 2022 11:25 CET Original file -
article xml file uploaded 15 November 2022 02:57 CET Update -
article xml uploaded. 15 November 2022 02:57 CET Update https://www.mdpi.com/2072-6694/14/22/5576/xml
article pdf uploaded. 15 November 2022 02:57 CET Updated version of record https://www.mdpi.com/2072-6694/14/22/5576/pdf
article supplementary file uploaded. 15 November 2022 02:57 CET - https://www.mdpi.com/2072-6694/14/22/5576#supplementary
article html file updated 15 November 2022 02:59 CET Update -
article html file updated 18 November 2022 06:54 CET Update -
article supplementary file uploaded. 18 November 2022 07:19 CET - https://www.mdpi.com/2072-6694/14/22/5576#supplementary
article html file updated 28 February 2023 22:55 CET Update -
article html file updated 2 March 2023 23:13 CET Update https://www.mdpi.com/2072-6694/14/22/5576/html
Back to TopTop